Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

We are delighted to announce that Professor KJ Patel has been appointed as the new Director of the MRC Weatherall Institute of Molecular Medicine and the MRC Molecular Haematology Unit at the University of Oxford.

Professor KJ Patel FRS FMedSci will start full-time as Director of the MRC Weatherall Institute of Molecular Medicine (MRC WIMM) and the MRC Molecular Haematology Unit (MRC MHU) from 1st June 2020. Between 1st April to 31st May, Professor Patel will be managing these two roles on a part-time basis, whilst transitioning his research programme from the MRC Laboratory of Molecular Biology in Cambridge (MRC LMB), where he is currently based.

Professor Hugh Watkins, Head of the Radcliffe Department of Medicine, said “I am delighted to welcome KJ to the department and am excited about his vision for the MRC MHU and the MRC WIMM. KJ is a scientist of the highest distinction whose own work epitomises how fundamental molecular insights drive important medical advances.”

Professor Patel trained as a physician in London, specialising in gastroenterology. He completed a PhD with the late Michael Neuberger FRS at the MRC LMB in B cell immunology, and later returned to the MRC LMB as an MRC Clinician Scientist working with Professor Ashok Venkitaraman FMedSci. There, he and others discovered that BRCA2 is a DNA repair factor.

“I am delighted to be appointed to this position” said Professor Patel “When preparing for an exam as a medical student, I was given a book that I read overnight and changed the course of my career. The book was ‘Genetics and Clinical Medicine’ by David Weatherall. So it seems fitting that I find myself coming to the MRC WIMM at this stage of my career, considering the impact that it had on me at the start of it.”

Professor Patel is also a Fellow of the Royal Society and the Academy of Medical Sciences, and a member of EMBO. The Patel group currently investigates the genetic and physiological foundations of DNA crosslink repair, explaining why this is essential in haematopoiesis.

Similar stories

Mechanism behind repair of cancer-inducing mutations discovered

New Nature paper uncovers the precise mechanism behind how the BRCA1 protein detects and engages with DNA breaks in the genome, helping to prevent the development of breast and ovarian cancers.

DNA breakthrough could help identify why some people are more affected by Covid-19

Scientists from the MRC Weatherall Institute of Molecular Medicine have developed a method that allows them to see, with far greater accuracy, how DNA forms large scale structures within a cell nucleus.

New clinical trial for patients affected by blood cancer

Radcliffe Department of Medicine's Professor Adam Mead is leading PROMise, a new clinical trial offering a novel treatment option for patients with a type of blood cancer called myelofibrosis.

Immune cells imperfect at distinguishing friend from foe

When it comes to distinguishing a healthy cell from an infected one that needs to be destroyed, the immune system’s killer T cells sometimes make mistakes. This discovery, described today in the journal eLife, upends a long-held belief among scientists that T cells were nearly perfect at discriminating friend from foe. The results may point to new ways to treat autoimmune diseases that cause the immune system to attack the body, or lead to improvements in cutting-edge cancer treatments.

Professor Graham Ogg elected Academy of Medical Sciences Fellow

Fellows are selected for their exceptional contributions to the advancement of medical science through innovative research discoveries and translating scientific developments into benefits for patients and the wider society.